YBGJ Stock: Yubo International Biotech Limited Stock Price, Analysis & Insights
Get live YBGJ stock price $0.01, comprehensive Yubo International Biotech Limited stock analysis, charts, news, and expert forecast. Real-time YBGJ stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a div...
Company Information
- CEO
- Yang Wang
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 18
Contact Information
- Website
- https://www.yubogroup.com
- Address
- Building 5
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.64) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Yubo International Biotech Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Yubo International Biotech Limited
- ⚠Investors should consider how Yubo International Biotech Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.01M
P/E Ratio (TTM)
-0.84
Beta
0.64
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare YBGJ with peer companies:
- Price
- $0.00
- Market cap
- 2.07M
- Price
- $0.00
- Market cap
- 19.96K
- Price
- $0.00
- Market cap
- 959.68K
- Price
- $0.00
- Market cap
- 882.95K
- Price
- $0.00
- Market cap
- 313
- Price
- $0.08
- Market cap
- 1.67M
- Price
- $0.00
- Market cap
- 2.32K
- Price
- $0.08
- Market cap
- 851.18K
- Price
- $0.00
- Market cap
- 20.41K
- Price
- $0.00
- Market cap
- 1.84M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.